These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 8895526
1. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Cook DM, Hinkes MT, Bernfield M, Rauscher FJ. Oncogene; 1996 Oct 17; 13(8):1789-99. PubMed ID: 8895526 [Abstract] [Full Text] [Related]
3. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. Cancer Res; 1995 Oct 15; 55(20):4540-3. PubMed ID: 7553624 [Abstract] [Full Text] [Related]
4. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J. Oncogene; 1996 Aug 01; 13(3):447-53. PubMed ID: 8760285 [Abstract] [Full Text] [Related]
5. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 2):2571-80. PubMed ID: 9815658 [Abstract] [Full Text] [Related]
6. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Zhang X, Xing G, Saunders GF. Anticancer Res; 1999 Dec 01; 19(3A):1641-8. PubMed ID: 10470095 [Abstract] [Full Text] [Related]
7. Wilms tumor and the WT1 gene. Lee SB, Haber DA. Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525 [Abstract] [Full Text] [Related]
8. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1. Li RS, Law GL, Seifert RA, Romaniuk PJ, Morris DR. Exp Cell Res; 1999 Feb 25; 247(1):257-66. PubMed ID: 10047468 [Abstract] [Full Text] [Related]
9. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG. Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497 [Abstract] [Full Text] [Related]
10. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter. Lee TH, Pelletier J. Physiol Genomics; 2001 Dec 21; 7(2):187-200. PubMed ID: 11773605 [Abstract] [Full Text] [Related]
11. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG. Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710 [Abstract] [Full Text] [Related]
12. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Sakamoto Y, Yoshida M, Semba K, Hunter T. Oncogene; 1997 Oct 23; 15(17):2001-12. PubMed ID: 9366517 [Abstract] [Full Text] [Related]
13. Functional properties of WT1. Haber DA, Englert C, Maheswaran S. Med Pediatr Oncol; 1996 Nov 23; 27(5):453-5. PubMed ID: 8827073 [Abstract] [Full Text] [Related]
14. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB. Dehbi M, Hiscott J, Pelletier J. Oncogene; 1998 Apr 23; 16(16):2033-9. PubMed ID: 9572484 [Abstract] [Full Text] [Related]
15. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene. Anant S, Axenovich SA, Madden SL, Rauscher FJ, Subramanian KN. Oncogene; 1994 Nov 23; 9(11):3113-26. PubMed ID: 7936634 [Abstract] [Full Text] [Related]
20. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Sim EU, Smith A, Szilagi E, Rae F, Ioannou P, Lindsay MH, Little MH. Oncogene; 2002 May 02; 21(19):2948-60. PubMed ID: 12082525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]